No abstract available
MeSH terms
-
Ado-Trastuzumab Emtansine / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism*
-
Breast Neoplasms / mortality
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Erb-b2 Receptor Tyrosine Kinases / metabolism*
-
Female
-
Humans
-
Randomized Controlled Trials as Topic
Substances
-
Ado-Trastuzumab Emtansine
-
Antibodies, Monoclonal, Humanized
-
Erb-b2 Receptor Tyrosine Kinases
-
ERBB2 protein, human